Searched over 200M research papers
10 papers analyzed
Some studies suggest that cough in congestive heart failure patients can be a side effect of ACE inhibitors and may require discontinuation, while other studies indicate that cough is not always directly linked to heart failure and may be misleading in diagnosis.
20 papers analyzed
Congestive heart failure (CHF) is a chronic condition where the heart's ability to pump blood is inadequate, leading to symptoms such as shortness of breath, fatigue, and fluid retention. One of the less commonly discussed symptoms of CHF is cough, which can be both a direct and indirect consequence of the disease.
Recent advancements in technology have led to innovative methods for early detection of CHF-related cough. The TussisWatch system, for instance, utilizes smartphone technology to record and analyze cough episodes, distinguishing between those caused by CHF and other conditions like chronic obstructive pulmonary disease (COPD). This system employs a two-level classification scheme to accurately identify coughs indicative of CHF, potentially aiding in early diagnosis and management.
Angiotensin-converting enzyme inhibitors (ACE inhibitors) are commonly prescribed for managing CHF due to their vasodilatory effects. However, a significant side effect of these medications is a persistent dry cough. Studies have shown that this cough occurs in approximately 26% of CHF patients on ACE inhibitors, often leading to discontinuation of the therapy . The incidence of cough is notably higher in CHF patients compared to those with hypertension, highlighting the need for careful monitoring and alternative treatments in affected individuals.
In some cases, antibiotics have been explored as a treatment for CHF patients whose primary symptom is a cough. However, research indicates that the addition of antibiotics to standard CHF therapy does not significantly improve outcomes, suggesting that antibiotics should not be routinely used for managing cough in CHF patients unless there is a clear indication of a bacterial infection.
Interestingly, research on dogs with CHF has provided additional insights into the relationship between heart failure and cough. Studies have shown that while cough is a common symptom in dogs with myxomatous mitral valve disease (MMVD), it is not directly associated with CHF. Instead, factors such as abnormal airway patterns and left atrial enlargement are more significant predictors of cough in these animals . This finding underscores the complexity of diagnosing and managing cough in CHF, whether in humans or animals.
CHF is typically associated with older adults, but it can also occur in younger individuals due to conditions like tachycardia-induced cardiomyopathy (TIC). In such cases, chronic cough may be a presenting symptom. Effective management of the underlying arrhythmia often leads to resolution of both the cough and heart failure symptoms, emphasizing the importance of considering CHF in the differential diagnosis of chronic cough in younger patients.
Cough is a multifaceted symptom in congestive heart failure, influenced by medication side effects, underlying cardiac conditions, and other comorbidities. Advances in diagnostic technology, such as the TussisWatch system, and a better understanding of the side effects of treatments like ACE inhibitors, are crucial for improving patient outcomes. Additionally, recognizing the unique presentations of CHF-related cough in different populations, including young patients and animals, can aid in more accurate diagnosis and effective management.
Most relevant research papers on this topic